Orrell R W, Marklund S L, deBelleroche J S
Department of Biochemistry, Charing Cross and Westminster Medical School, Charing Cross Hospital, London, UK.
J Neurol Sci. 1997 Dec 9;153(1):46-9. doi: 10.1016/s0022-510x(97)00181-0.
Mutations of the SOD1 gene, which encodes the enzyme copper/zinc superoxide dismutase, are associated with familial amyotrophic lateral sclerosis (ALS). SOD1 consists of five exons, and over 50 different mutations have been described involving exons 1,2,4 and 5. The absence of mutations in exon 3 has been attributed to a critical function of this exon, its integrity being necessary for the toxic effect of mutant SOD1, and it has been suggested that such mutations may be lethal rather than leading to adult onset disease. We identified the heterozygote mutation Gly72Ser (exon 3) in a family with two individuals affected by ALS. SOD enzyme activity was reduced by 45% when measured in erythrocytes indicating reduced enzyme activity, or reduced stability of the mutant protein. These findings indicate that exon 3 is not a privileged region from mutation; that all five exons should be investigated when seeking SOD1 mutations in human disease; and may help in a better understanding of the pathogenicity of these mutations in ALS.
编码铜/锌超氧化物歧化酶的SOD1基因突变与家族性肌萎缩侧索硬化症(ALS)相关。SOD1由五个外显子组成,已描述了涉及外显子1、2、4和5的50多种不同突变。外显子3中无突变归因于该外显子的关键功能,其完整性对于突变型SOD1的毒性作用是必需的,并且有人提出此类突变可能是致死性的,而不是导致成人发病疾病。我们在一个有两名ALS患者的家族中鉴定出杂合子突变Gly72Ser(外显子3)。当在红细胞中测量时,SOD酶活性降低了45%,表明酶活性降低或突变蛋白稳定性降低。这些发现表明外显子3并非突变的特权区域;在人类疾病中寻找SOD1突变时应研究所有五个外显子;并且可能有助于更好地理解这些突变在ALS中的致病性。